Akers Biosciences (AKER) Surges Amid First OxiChek Distribution Agreement
Tweet Send to a Friend
Akers Biosciences (NASDAQ: AKER) is surging 45% in early trade after the company announced it signed its first distribution agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
